Fluidigm Posts 26 Percent Revenue Growth for Q1 | GenomeWeb

NEW YORK (GenomeWeb News) – Fluidigm reported after the close of the market Thursday that its first-quarter revenues increased 26 percent with strong growth for both its instruments and consumables.

The South San Francisco, Calif.-based firm had total revenues of $10.9 million for the three months ended March 31, compared to $8.7 million for the first quarter of 2011. It beat Wall Street's estimate for revenues of $10.8 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: vervet genome, tandem repeats affect gene expression in great apes, and more.

Wired's Sarah Zhang writes that the fight over who developed the CRISPR/Cas9 genome editing tool first underscores the history of parallel discoveries in science.

Recent research indicates that the benefit of having a number of scientists all living and working in a certain area is eroding.

Tomas Lindahl, Paul Modrich, and Aziz Sancar share this year's Nobel Prize in Chemistry for their studies of DNA repair mechanisms.